annual current assets:
$747.16M+$315.47M(+73.08%)Summary
- As of today (June 23, 2025), CLDX annual total current assets is $747.16 million, with the most recent change of +$315.47 million (+73.08%) on December 31, 2024.
- During the last 3 years, CLDX annual current assets has risen by +$336.32 million (+81.86%).
- CLDX annual current assets is now at all-time high.
Performance
CLDX Current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current assets:
$693.76M-$53.40M(-7.15%)Summary
- As of today (June 23, 2025), CLDX quarterly total current assets is $693.76 million, with the most recent change of -$53.40 million (-7.15%) on March 31, 2025.
- Over the past year, CLDX quarterly current assets has dropped by -$141.57 million (-16.95%).
- CLDX quarterly current assets is now -16.95% below its all-time high of $835.32 million, reached on March 31, 2024.
Performance
CLDX quarterly current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
CLDX Current assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +73.1% | -16.9% |
| 3 y3 years | +81.9% | +77.6% |
| 5 y5 years | +1020.2% | +1140.7% |
CLDX Current assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +135.2% | -16.9% | +182.1% |
| 5 y | 5-year | at high | +1020.2% | -16.9% | +1140.7% |
| alltime | all time | at high | >+9999.0% | -16.9% | >+9999.0% |
CLDX Current assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $693.76M(-7.1%) |
| Dec 2024 | $45.18M(+33.1%) | $747.16M(-4.1%) |
| Sep 2024 | - | $778.84M(-4.1%) |
| Jun 2024 | - | $811.98M(-2.8%) |
| Mar 2024 | - | $835.32M(+93.5%) |
| Dec 2023 | $33.93M(-3.2%) | $431.69M(+75.5%) |
| Sep 2023 | - | $245.93M(-7.1%) |
| Jun 2023 | - | $264.82M(-8.6%) |
| Mar 2023 | - | $289.60M(-8.8%) |
| Dec 2022 | $35.04M(+3.6%) | $317.69M(-5.1%) |
| Sep 2022 | - | $334.60M(-9.1%) |
| Jun 2022 | - | $367.98M(-5.8%) |
| Mar 2022 | - | $390.70M(-4.9%) |
| Dec 2021 | $33.81M(-11.0%) | $410.84M(-3.7%) |
| Sep 2021 | - | $426.56M(+154.5%) |
| Jun 2021 | - | $167.61M(-7.7%) |
| Mar 2021 | - | $181.50M(-8.3%) |
| Dec 2020 | $37.99M(-32.4%) | $197.84M(-2.5%) |
| Sep 2020 | - | $202.93M(-2.9%) |
| Jun 2020 | - | $208.99M(+273.7%) |
| Mar 2020 | - | $55.92M(-16.2%) |
| Dec 2019 | $56.23M(-0.9%) | $66.70M(-11.2%) |
| Sep 2019 | - | $75.10M(-11.0%) |
| Jun 2019 | - | $84.36M(-5.0%) |
| Mar 2019 | - | $88.85M(-10.3%) |
| Dec 2018 | $56.73M(-66.8%) | $99.08M(-10.7%) |
| Sep 2018 | - | $110.97M(-7.7%) |
| Jun 2018 | - | $120.28M(-8.2%) |
| Mar 2018 | - | $130.97M(-9.5%) |
| Dec 2017 | $170.87M(-9.0%) | $144.76M(-1.7%) |
| Sep 2017 | - | $147.32M(-8.0%) |
| Jun 2017 | - | $160.05M(-7.7%) |
| Mar 2017 | - | $173.46M(-11.3%) |
| Dec 2016 | $187.79M(+340.3%) | $195.57M(-6.7%) |
| Sep 2016 | - | $209.71M(-8.3%) |
| Jun 2016 | - | $228.78M(-12.3%) |
| Mar 2016 | - | $260.95M(-11.5%) |
| Dec 2015 | $42.65M(-0.9%) | $294.94M(-4.6%) |
| Sep 2015 | - | $309.26M(-8.9%) |
| Jun 2015 | - | $339.54M(-6.8%) |
| Mar 2015 | - | $364.13M(+77.6%) |
| Dec 2014 | $43.03M(+2.7%) | $204.99M(-10.8%) |
| Sep 2014 | - | $229.82M(-10.1%) |
| Jun 2014 | - | $255.60M(-7.7%) |
| Mar 2014 | - | $276.82M(-9.3%) |
| Dec 2013 | $41.91M(+3.7%) | $305.19M(+118.1%) |
| Sep 2013 | - | $139.95M(-10.5%) |
| Jun 2013 | - | $156.43M(-15.2%) |
| Mar 2013 | - | $184.45M(+116.7%) |
| Dec 2012 | $40.43M(-6.7%) | $85.11M(+8.0%) |
| Sep 2012 | - | $78.81M(-2.0%) |
| Jun 2012 | - | $80.40M(-14.7%) |
| Mar 2012 | - | $94.24M(+72.3%) |
| Dec 2011 | $43.31M(-7.8%) | $54.68M(-15.1%) |
| Sep 2011 | - | $64.38M(-12.2%) |
| Jun 2011 | - | $73.29M(+58.5%) |
| Mar 2011 | - | $46.23M(-26.6%) |
| Dec 2010 | $47.00M(-16.7%) | $62.95M(+6.3%) |
| Sep 2010 | - | $59.20M(-13.3%) |
| Jun 2010 | - | $68.25M(-12.8%) |
| Mar 2010 | - | $78.28M(-6.8%) |
| Dec 2009 | $56.39M(+148.2%) | $83.98M(+199.8%) |
| Sep 2009 | - | $28.01M(-16.4%) |
| Jun 2009 | - | $33.51M(-19.9%) |
| Mar 2009 | - | $41.84M(-11.1%) |
| Dec 2008 | $22.72M(+518.0%) | $47.08M(-15.3%) |
| Sep 2008 | - | $55.56M(-19.5%) |
| Jun 2008 | - | $69.03M(+204.4%) |
| Mar 2008 | - | $22.68M(+298.0%) |
| Dec 2007 | $3.68M(-80.7%) | $5.70M(-73.3%) |
| Sep 2007 | - | $21.38M(-21.8%) |
| Jun 2007 | - | $27.33M(-19.4%) |
| Mar 2007 | - | $33.92M(-20.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $19.08M(+61.0%) | $42.40M(-12.0%) |
| Sep 2006 | - | $48.16M(-12.4%) |
| Jun 2006 | - | $54.99M(-10.2%) |
| Mar 2006 | - | $61.25M(+148.9%) |
| Dec 2005 | $11.85M(+5.2%) | $24.60M(-13.9%) |
| Sep 2005 | - | $28.59M(-13.6%) |
| Jun 2005 | - | $33.09M(+14.5%) |
| Mar 2005 | - | $28.89M(-16.3%) |
| Dec 2004 | $11.26M(+25.2%) | $34.54M(-5.7%) |
| Sep 2004 | - | $36.61M(-8.9%) |
| Jun 2004 | - | $40.20M(-7.5%) |
| Mar 2004 | - | $43.44M(+94.7%) |
| Dec 2003 | $9.00M(-4.0%) | $22.31M(-10.0%) |
| Sep 2003 | - | $24.78M(+37.4%) |
| Jun 2003 | - | $18.04M(-13.8%) |
| Mar 2003 | - | $20.92M(-19.1%) |
| Dec 2002 | $9.37M(-7.6%) | $25.86M(-11.3%) |
| Sep 2002 | - | $29.14M(-10.3%) |
| Jun 2002 | - | $32.48M(-14.0%) |
| Mar 2002 | - | $37.76M(-12.9%) |
| Dec 2001 | $10.14M(-13.7%) | $43.34M(+20.7%) |
| Sep 2001 | - | $35.91M(-15.3%) |
| Jun 2001 | - | $42.41M(-9.3%) |
| Mar 2001 | - | $46.77M(-9.7%) |
| Dec 2000 | $11.76M(+118.0%) | $51.81M(+4.5%) |
| Sep 2000 | - | $49.57M(+192.5%) |
| Jun 2000 | - | $16.95M(-14.0%) |
| Mar 2000 | - | $19.70M(+36.0%) |
| Dec 1999 | $5.39M(-23.5%) | $14.49M(-17.7%) |
| Sep 1999 | - | $17.60M(+74.3%) |
| Jun 1999 | - | $10.10M(-21.1%) |
| Mar 1999 | - | $12.80M(-17.9%) |
| Dec 1998 | $7.05M(+193.8%) | $15.60M(-4.3%) |
| Sep 1998 | - | $16.30M(+143.3%) |
| Jun 1998 | - | $6.70M(-26.4%) |
| Mar 1998 | - | $9.10M(+23.0%) |
| Dec 1997 | $2.40M(-38.5%) | $7.40M(-17.8%) |
| Sep 1997 | - | $9.00M(-18.2%) |
| Jun 1997 | - | $11.00M(-12.7%) |
| Mar 1997 | - | $12.60M(-5.3%) |
| Dec 1996 | $3.90M(-20.4%) | $13.30M(-11.9%) |
| Sep 1996 | - | $15.10M(+104.1%) |
| Jun 1996 | - | $7.40M(-26.7%) |
| Mar 1996 | - | $10.10M(-25.7%) |
| Dec 1995 | $4.90M(+63.3%) | $13.60M(+76.6%) |
| Sep 1995 | - | $7.70M(-35.8%) |
| Jun 1995 | - | $12.00M(-20.5%) |
| Mar 1995 | - | $15.10M(-14.7%) |
| Dec 1994 | $3.00M(-16.7%) | $17.70M(-16.9%) |
| Sep 1994 | - | $21.30M(-10.5%) |
| Jun 1994 | - | $23.80M(-12.5%) |
| Mar 1994 | - | $27.20M(-7.8%) |
| Dec 1993 | $3.60M(+12.5%) | $29.50M(+116.9%) |
| Sep 1993 | - | $13.60M(-13.4%) |
| Jun 1993 | - | $15.70M(-11.3%) |
| Mar 1993 | - | $17.70M(-16.9%) |
| Dec 1992 | $3.20M(+14.3%) | - |
| Oct 1992 | - | $21.30M(-7.4%) |
| Jul 1992 | - | $23.00M(-5.0%) |
| Apr 1992 | - | $24.20M(-4.3%) |
| Apr 1992 | $2.80M(+7.7%) | - |
| Jan 1992 | - | $25.30M(-1.9%) |
| Oct 1991 | - | $25.80M(-4.8%) |
| Jul 1991 | - | $27.10M(+155.7%) |
| Apr 1991 | $2.60M(-10.3%) | $10.60M(+6.0%) |
| Jan 1991 | - | $10.00M(-7.4%) |
| Oct 1990 | - | $10.80M(-12.9%) |
| Jul 1990 | - | $12.40M(-2.4%) |
| Apr 1990 | $2.90M(+16.0%) | $12.70M(+38.0%) |
| Jan 1990 | - | $9.20M(-14.0%) |
| Apr 1989 | $2.50M(+78.6%) | $10.70M(-7.8%) |
| Apr 1988 | $1.40M(+133.3%) | $11.60M(-17.1%) |
| Apr 1987 | $600.00K(+50.0%) | $14.00M(+400.0%) |
| Apr 1986 | $400.00K | $2.80M |
FAQ
- What is Celldex Therapeutics annual total current assets?
- What is the all time high annual current assets for Celldex Therapeutics?
- What is Celldex Therapeutics annual current assets year-on-year change?
- What is Celldex Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly current assets year-on-year change?
What is Celldex Therapeutics annual total current assets?
The current annual current assets of CLDX is $747.16M
What is the all time high annual current assets for Celldex Therapeutics?
Celldex Therapeutics all-time high annual total current assets is $747.16M
What is Celldex Therapeutics annual current assets year-on-year change?
Over the past year, CLDX annual total current assets has changed by +$315.47M (+73.08%)
What is Celldex Therapeutics quarterly total current assets?
The current quarterly current assets of CLDX is $693.76M
What is the all time high quarterly current assets for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly total current assets is $835.32M
What is Celldex Therapeutics quarterly current assets year-on-year change?
Over the past year, CLDX quarterly total current assets has changed by -$141.57M (-16.95%)